業績 Performance

論文

海外誌

  • Onozato D, Akagawa T, Kida Y, Ogawa I, Hashita T, Iwao T, Matsunaga T.
    Application of human induced pluripotent stem cell-derived intestinal organoids as a model of epithelial damage and fibrosis in inflammatory bowel disease.
    Biol Pharm Bull. 42(7);1088-95:2020.
  • Yamashita M, Aoki H, Hashita T, Iwao T, Matsunaga T.
    Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells.
    Fluids Barriers CNS. 17(1):36:2020.
  • Aoki H, Yamashita M, Hashita T, Ogami K, Hoshino S, Iwao T, Matsunaga T.
    Laminin 221 fragment is suitable for the differentiation of human induced pluripotent stem cells into brain microvascular endothelial-like cells with robust barrier integrity.
    Fluids Barrier CNS. 17(1);25:2020.
  • Aoki H, Yamashita M, Hashita T, Ogami K, Hoshino S, Iwao T, Matsunaga T.
    Efficient differentiation and purification of human induced pluripotent stem cell-derived endothelial progenitor cells and expansion with the use of inhibitors of ROCK, TGF-β, and GSK3β.
    Heliyon. 6(3);e03493:2020.
  • Kondo S, Mizuno S, Hashita T, Iwao T, Matsunaga T.
    Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.
    Biol. Open. 9(1):bio049064:2020.